The aim of this study is to conduct an in-depth analysis of the Burden of Disease (BoD) perceived by patients with Hereditary Angioedema (HAE), through daily prospective observations based on Ecological Momentary Assessment (EMA) via digital surveys and standardised questionnaires. Participants will answer online survey questions about their perceived burden of disease for 8 consecutive weeks. The main hypothesis is that daily prospective observation (EMA) will reveal a higher and more fluctuating burden of disease compared to traditional retrospective scales, providing a more accurate representation of the impact of HAE on patients' daily lives.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Emotional Burden via Ecological Momentary Assessment (EMA)
Timeframe: Every other day for 8 weeks
Socio-occupational Impairment via Ecological Momentary Assessment (EMA)
Timeframe: Every other day for 8 weeks
Disease Activity
Timeframe: AAS is collected every other day for 8 weeks
Angioedema Quality of Life
Timeframe: After 4 weeks and at the end of the 8 weeks
Disease Control
Timeframe: After 4 weeks and at the end of the 8 weeks.